celecoxib has been researched along with Mesothelioma in 3 studies
Mesothelioma: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib was more efficient in inhibiting MM cell growth than acetylsalicylic acid (10(-6) M-10(-2) M), indometacin (10(-6) M-10(-2) M) and the COX-2 inhibitor NS-398 (10(-6) M-10(-4) M)." | 5.32 | Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention. ( Amoroso, S; Betta, P; Catalano, A; Gianni, W; Graciotti, L; Procopio, A; Raffaelli, G; Rinaldi, L; Rodilossi, S, 2004) |
| "Celecoxib is a potent selective COX-2 inhibitor." | 5.32 | [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP]. ( Hada, M; Kazuhiro, M, 2004) |
| "Celecoxib is a potent selective COX-2 inhibitor." | 1.32 | [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP]. ( Hada, M; Kazuhiro, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veltman, JD | 1 |
| Lambers, ME | 1 |
| van Nimwegen, M | 1 |
| Hendriks, RW | 1 |
| Hoogsteden, HC | 1 |
| Aerts, JG | 1 |
| Hegmans, JP | 1 |
| Catalano, A | 1 |
| Graciotti, L | 1 |
| Rinaldi, L | 1 |
| Raffaelli, G | 1 |
| Rodilossi, S | 1 |
| Betta, P | 1 |
| Gianni, W | 1 |
| Amoroso, S | 1 |
| Procopio, A | 1 |
| Hada, M | 1 |
| Kazuhiro, M | 1 |
3 other studies available for celecoxib and Mesothelioma
| Article | Year |
|---|---|
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
Topics: Animals; Blotting, Western; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dendritic Cell | 2010 |
Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspases; Celecoxib; Chemopr | 2004 |
[A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cisplatin; Combined Modality Therapy; Dru | 2004 |